Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Ultragenyx (RARE) has a market cap of $3.32 billion USD. According to our data, Ultragenyx is ranked No.3203 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $3.32 B |
-14.58%
|
| Dec 31, 2024 | $3.88 B |
-12.02%
|
| Dec 29, 2023 | $4.42 B |
3.22%
|
| Dec 30, 2022 | $4.28 B |
-44.90%
|
| Dec 31, 2021 | $7.77 B |
-39.25%
|
| Dec 31, 2020 | $12.78 B |
224.12%
|
| Dec 31, 2019 | $3.94 B |
-1.77%
|
| Dec 31, 2018 | $4.02 B |
-6.25%
|
| Dec 29, 2017 | $4.28 B |
-34.03%
|
| Dec 30, 2016 | $6.49 B |
-37.32%
|
| Dec 31, 2015 | $10.36 B |
155.65%
|
| Dec 31, 2014 | $4.05 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Illumina
ILMN
|
$11.80 B |
-0.000 M
|
USA
|
 Catalyst Pharmaceuticals
CPRX
|
$2.83 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 ACADIA Pharmaceuticals
ACAD
|
$2.50 B |
-0.000 M
|
USA
|
| Market Cap | = | RARE Stock Price | * | RARE Shares Outstanding |
| = | $35.34 | * | 93.90 M | |
| = | $3.32 B |